Ovarian Cancer

Erythropoiesis-Stimulating Agent Use After Changes in Medicare Reimbursement Policies

Since 2004, concerns about the safety of erythropoiesis-stimulating agents (ESAs) have resulted in label changes and restrictions on …

Dawn L. Hershman, Alfred I. Neugut, Jinjoo Shim, Sherry Glied, Wei-Yann Tsai, Jason D. Wright